Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oxidants and free radicals in inflammatory bowel disease.

× No keyword cloud information.

123 in total

1. Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors: Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal: World J Gastroenterol Date: 1998-10 Impact factor: 5.742

2. p53 antibodies, metallothioneins, and oxidative stress markers in chronic ulcerative colitis with dysplasia.

Authors: Hala E Hamouda; Soha S Zakaria; Saber A Ismail; Mahmoud A Khedr; Wael W Mayah
Journal: World J Gastroenterol Date: 2011-05-21 Impact factor: 5.742

3. Nitric oxide effect on colonocyte metabolism: co-action of sulfides and peroxide.

Authors: W E Roediger; W J Babidge
Journal: Mol Cell Biochem Date: 2000-03 Impact factor: 3.396

4. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease.

Authors: S J McKenzie; M S Baker; G D Buffinton; W F Doe
Journal: J Clin Invest Date: 1996-07-01 Impact factor: 14.808

Review 5. Radical induction theory of ulcerative colitis.

Authors: Jay Pravda
Journal: World J Gastroenterol Date: 2005-04-28 Impact factor: 5.742

6. Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats.

Authors: C Loguercio; G D'Argenio; M Delle Cave; V Cosenza; N Della Valle; G Mazzacca; C del Vecchio Blanco
Journal: Dig Dis Sci Date: 1996-06 Impact factor: 3.199

7. High prevalence of vitamin A deficiency in Crohn's disease patients according to serum retinol levels and the relative dose-response test.

Authors: Márcia Soares-Mota; Tianny A Silva; Luanda M Gomes; Marco A S Pinto; Laura M C Mendonça; Maria Lúcia F Farias; Tiago Nunes; Andrea Ramalho; Cyrla Zaltman
Journal: World J Gastroenterol Date: 2015-02-07 Impact factor: 5.742

8. Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study.

Authors: C Romano; S Cucchiara; A Barabino; V Annese; C Sferlazzas
Journal: World J Gastroenterol Date: 2005-12-07 Impact factor: 5.742

9. Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.

Authors: E Furrie; S Macfarlane; J H Cummings; G T Macfarlane
Journal: Gut Date: 2004-01 Impact factor: 23.059

10. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease.

Authors: Ioannis E Koutroubakis; Niki Malliaraki; Philippos D Dimoulios; Konstantinos Karmiris; Elias Castanas; Elias A Kouroumalis
Journal: Dig Dis Sci Date: 2004-09 Impact factor: 3.199